Global Health Gateway
Welcome to BioMed Central's Global Health Gateway, highlighting the latest articles we have published in this field. Content is continually updated, so please bookmark this page and ensure you check it regularly.
Mark Wainberg and colleagues argue that as the HIV integrase inhibitor, Dolutegravir (DTG), does not select for resistance mutations when used in first-line therapy, it may potentially play a role in long-term treatment and management of HIV.
Krassimir Yankulov and colleagues summarize recent advances in parasite epigenetics and emphasise the similarities between budding yeast and pathogens like Plasmodium, Trypanosoma, Candida and Pneumocystis.
This study revealed that car crashes are the most common cause of pediatric trauma, with an overall mortality of 13%. The findings provide a valuable insight into trauma care in the East-African region not covered by the most recent World Health Organization's Global Status Report on Road Safety.
Following initiation of highly active anti-retroviral therapy there is a significant association between low CCL3L1 gene copy number and improved immune reconstitution in patients, which is not seen prior to the start of drug treatment.
A mixed methods study of community understanding and perceptions of health insurance in Kenya suggests it is important that communities are educated and engaged to ensure the national health insurance scheme is acceptable to the population.
BMC Medical Informatics and Decision Making 2013, 13(Suppl 3):S7
Malaria Journal 2013, 12:442
Lipids in Health and Disease 2013, 12:179